Annual Net Income
-$11.12 M
+$16.30 M+59.45%
31 December 2023
Summary:
Processa Pharmaceuticals annual net profit is currently -$11.12 million, with the most recent change of +$16.30 million (+59.45%) on 31 December 2023. During the last 3 years, it has risen by +$3.29 million (+22.84%). PCSA annual net income is now -3209.97% below its all-time high of -$336.00 thousand, reached on 31 December 2016.PCSA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$3.38 M
-$374.40 K-12.44%
30 September 2024
Summary:
Processa Pharmaceuticals quarterly net profit is currently -$3.38 million, with the most recent change of -$374.40 thousand (-12.44%) on 30 September 2024. Over the past year, it has dropped by -$1.30 million (-62.57%). PCSA quarterly net income is now -7789.74% below its all-time high of -$42.90 thousand, reached on 30 June 2017.PCSA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$11.53 M
-$1.30 M-12.74%
30 September 2024
Summary:
Processa Pharmaceuticals TTM net profit is currently -$11.53 million, with the most recent change of -$1.30 million (-12.74%) on 30 September 2024. Over the past year, it has increased by +$10.20 million (+46.95%). PCSA TTM net income is now -4052.13% below its all-time high of -$277.60 thousand, reached on 30 June 2017.PCSA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCSA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.5% | -62.6% | +47.0% |
| 3 y3 years | +22.8% | -13.3% | +35.9% |
| 5 y5 years | -195.4% | -292.0% | -261.0% |
PCSA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +59.5% | -62.6% | +74.0% | -17.3% | +59.1% |
| 5 y | 5 years | -231.2% | +59.5% | -361.5% | +74.0% | -261.0% | +59.1% |
| alltime | all time | -3210.0% | +59.5% | -7789.7% | +74.0% | -4052.1% | +59.1% |
Processa Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.38 M(+12.4%) | -$11.53 M(+12.7%) |
| June 2024 | - | -$3.01 M(+10.4%) | -$10.22 M(+4.0%) |
| Mar 2024 | - | -$2.73 M(+13.4%) | -$9.83 M(-11.7%) |
| Dec 2023 | -$11.12 M(-59.4%) | -$2.40 M(+15.5%) | -$11.12 M(-48.8%) |
| Sept 2023 | - | -$2.08 M(-20.3%) | -$21.73 M(-15.3%) |
| June 2023 | - | -$2.61 M(-35.0%) | -$25.67 M(-9.0%) |
| Mar 2023 | - | -$4.02 M(-69.1%) | -$28.22 M(+2.9%) |
| Dec 2022 | -$27.42 M(+140.0%) | -$13.01 M(+116.1%) | -$27.42 M(+55.9%) |
| Sept 2022 | - | -$6.02 M(+16.6%) | -$17.60 M(+20.8%) |
| June 2022 | - | -$5.16 M(+60.0%) | -$14.56 M(+16.0%) |
| Mar 2022 | - | -$3.23 M(+1.4%) | -$12.56 M(+9.9%) |
| Dec 2021 | -$11.43 M(-20.7%) | -$3.18 M(+6.6%) | -$11.43 M(-36.4%) |
| Sept 2021 | - | -$2.99 M(-5.4%) | -$17.98 M(-0.5%) |
| June 2021 | - | -$3.16 M(+50.4%) | -$18.06 M(+15.5%) |
| Mar 2021 | - | -$2.10 M(-78.4%) | -$15.64 M(+8.5%) |
| Dec 2020 | -$14.41 M(+329.3%) | -$9.73 M(+217.0%) | -$14.41 M(+164.3%) |
| Sept 2020 | - | -$3.07 M(+318.8%) | -$5.45 M(+68.0%) |
| June 2020 | - | -$733.40 K(-16.1%) | -$3.25 M(-6.8%) |
| Mar 2020 | - | -$874.30 K(+12.9%) | -$3.48 M(+3.7%) |
| Dec 2019 | -$3.36 M(-10.8%) | -$774.40 K(-10.3%) | -$3.36 M(+5.2%) |
| Sept 2019 | - | -$863.50 K(-10.9%) | -$3.19 M(+0.3%) |
| June 2019 | - | -$969.10 K(+29.1%) | -$3.18 M(-6.9%) |
| Mar 2019 | - | -$750.80 K(+23.2%) | -$3.42 M(-9.2%) |
| Dec 2018 | -$3.77 M | -$609.20 K(-28.6%) | -$3.76 M(-19.7%) |
| Sept 2018 | - | -$852.80 K(-29.3%) | -$4.69 M(+16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$1.21 M(+10.0%) | -$4.04 M(+40.4%) |
| Mar 2018 | - | -$1.10 M(-28.5%) | -$2.88 M(+55.0%) |
| Dec 2017 | -$1.86 M(+452.5%) | -$1.53 M(+650.2%) | -$1.86 M(+348.7%) |
| Sept 2017 | - | -$204.40 K(+376.5%) | -$413.70 K(+49.0%) |
| June 2017 | - | -$42.90 K(-43.3%) | -$277.60 K(-0.1%) |
| Mar 2017 | - | -$75.60 K(-16.7%) | -$277.90 K(-17.3%) |
| Dec 2016 | -$336.00 K(-90.0%) | -$90.80 K(+32.9%) | -$335.90 K(-44.7%) |
| Sept 2016 | - | -$68.30 K(+58.1%) | -$607.90 K(-27.2%) |
| June 2016 | - | -$43.20 K(-67.7%) | -$835.30 K(-70.6%) |
| Mar 2016 | - | -$133.60 K(-63.2%) | -$2.84 M(-15.2%) |
| Dec 2015 | -$3.35 M(-25.9%) | -$362.80 K(+22.7%) | -$3.35 M(-26.0%) |
| Sept 2015 | - | -$295.70 K(-85.6%) | -$4.53 M(-9.9%) |
| June 2015 | - | -$2.05 M(+218.2%) | -$5.03 M(+31.4%) |
| Mar 2015 | - | -$644.60 K(-58.1%) | -$3.83 M(-15.5%) |
| Dec 2014 | -$4.53 M(+47.5%) | -$1.54 M(+94.3%) | -$4.53 M(+19.3%) |
| Sept 2014 | - | -$792.00 K(-7.0%) | -$3.79 M(+2.0%) |
| June 2014 | - | -$851.20 K(-36.7%) | -$3.72 M(+3.5%) |
| Mar 2014 | - | -$1.34 M(+66.6%) | -$3.60 M(+17.2%) |
| Dec 2013 | -$3.07 M(+25.7%) | -$806.90 K(+12.3%) | -$3.07 M(+0.8%) |
| Sept 2013 | - | -$718.80 K(-1.1%) | -$3.04 M(+4.0%) |
| June 2013 | - | -$726.60 K(-11.0%) | -$2.93 M(+9.4%) |
| Mar 2013 | - | -$816.40 K(+4.3%) | -$2.68 M(+9.7%) |
| Dec 2012 | -$2.44 M | -$782.90 K(+30.1%) | -$2.44 M(+47.2%) |
| Sept 2012 | - | -$601.90 K(+26.7%) | -$1.66 M(+57.0%) |
| June 2012 | - | -$475.10 K(-18.2%) | -$1.06 M(+81.8%) |
| Mar 2012 | - | -$580.60 K | -$580.60 K |
FAQ
- What is Processa Pharmaceuticals annual net profit?
- What is the all time high annual net income for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual net income year-on-year change?
- What is Processa Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly net income year-on-year change?
- What is Processa Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals TTM net income year-on-year change?
What is Processa Pharmaceuticals annual net profit?
The current annual net income of PCSA is -$11.12 M
What is the all time high annual net income for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual net profit is -$336.00 K
What is Processa Pharmaceuticals annual net income year-on-year change?
Over the past year, PCSA annual net profit has changed by +$16.30 M (+59.45%)
What is Processa Pharmaceuticals quarterly net profit?
The current quarterly net income of PCSA is -$3.38 M
What is the all time high quarterly net income for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly net profit is -$42.90 K
What is Processa Pharmaceuticals quarterly net income year-on-year change?
Over the past year, PCSA quarterly net profit has changed by -$1.30 M (-62.57%)
What is Processa Pharmaceuticals TTM net profit?
The current TTM net income of PCSA is -$11.53 M
What is the all time high TTM net income for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high TTM net profit is -$277.60 K
What is Processa Pharmaceuticals TTM net income year-on-year change?
Over the past year, PCSA TTM net profit has changed by +$10.20 M (+46.95%)